ES2061439T3 - Compuesto beta-lactama y su produccion. - Google Patents

Compuesto beta-lactama y su produccion.

Info

Publication number
ES2061439T3
ES2061439T3 ES86117997T ES86117997T ES2061439T3 ES 2061439 T3 ES2061439 T3 ES 2061439T3 ES 86117997 T ES86117997 T ES 86117997T ES 86117997 T ES86117997 T ES 86117997T ES 2061439 T3 ES2061439 T3 ES 2061439T3
Authority
ES
Spain
Prior art keywords
group
optionally protected
formula
hydrogen atom
carboxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86117997T
Other languages
English (en)
Inventor
Makoto Sumitomo Pharm Sunagawa
Yoshihito Sumitomo Phar Nozaki
Akira Sumitomo Pharmace Sasaki
Haruki Sumitomo Phar Matsumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Application granted granted Critical
Publication of ES2061439T3 publication Critical patent/ES2061439T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de beta-lactama de fórmula: **fórmula**, donde R es un grupo alquilo C4-C8, R2 es un grupo alilo de fórmula: **fórmula** (donde R3 y R4 son cada uno un átomo de hidrógeno, un grupo alquilo C1-C8 o un grupo arilo), un grupo beta-hidroxietilo en el que el grupo hidroxilo está opcionalmente protegido, un grupo formilmetilo en el que el grupo formilo está opcionalmente protegido o un grupo 2-furilmetilo y X es un grupo carboxilo opcionalmente protegido, un grupo hidroximetilo en el que el grupo hidroxilo está opcionalmente protegido o un grupo mercaptometilo sustituido de fórmula: -CH2SR5 (donde R5 es un grupo arilo o un grupo aralquilo C1-C8).
ES86117997T 1985-12-28 1986-12-23 Compuesto beta-lactama y su produccion. Expired - Lifetime ES2061439T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29699985 1985-12-28
JP18595886 1986-08-07

Publications (1)

Publication Number Publication Date
ES2061439T3 true ES2061439T3 (es) 1994-12-16

Family

ID=26503442

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86117997T Expired - Lifetime ES2061439T3 (es) 1985-12-28 1986-12-23 Compuesto beta-lactama y su produccion.

Country Status (6)

Country Link
US (1) US5134231A (es)
EP (1) EP0229384B1 (es)
JP (1) JPH0796547B2 (es)
AT (1) ATE109764T1 (es)
DE (1) DE3650023T2 (es)
ES (1) ES2061439T3 (es)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4344885A (en) * 1980-01-14 1982-08-17 Merck & Co., Inc. Intermediate for the preparation of thienamycin
JPS57123182A (en) * 1980-12-18 1982-07-31 Merck & Co Inc 6- and 4-substituted-1-azabicyclo(3,1,2,0)heptane- 3,7-dione-2-carboxylate
US4350631A (en) * 1980-12-18 1982-09-21 Merck & Co., Inc. 6- and 4-Substituted-1-azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylates
ES514240A0 (es) * 1981-08-03 1984-04-16 Merck & Co Inc Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
DE3581481D1 (de) * 1984-10-31 1991-02-28 Sumitomo Pharma Beta-lactame und ihre herstellung.
EP0184844A1 (en) * 1984-12-13 1986-06-18 Merck & Co. Inc. 1-Methylcarbapenems having a 2-position substituent joined through an alkylenethio bridge
NZ214691A (en) * 1984-12-27 1988-08-30 Sumitomo Pharma The preparation of carbapenem derivatives and beta-lactam intermediates
US4734497A (en) * 1985-02-19 1988-03-29 Merck & Co., Inc. Intermediates for process for chiral synthesis of 1-β-methyl-carbapenem intermediates
ES8800215A1 (es) * 1985-03-29 1987-10-16 Merck & Co Inc Un procedimiento enantioselectivo para la preparacion de intermedios para los antibioticos de 1-b-metil-carbapenem
JPS61275267A (ja) * 1985-03-29 1986-12-05 メルク　エンド　カムパニ−　インコ−ポレ−テツド １−β−メチルカルバペネム抗生物質中間体の鏡像異性選択的製造方法
JPH0635432B2 (ja) * 1985-06-06 1994-05-11 住友製薬株式会社 新規なβ−ラクタム化合物
JPH0657683B2 (ja) * 1985-11-15 1994-08-03 住友製薬株式会社 光学活性アミノ酸誘導体
JPS6229577A (ja) * 1985-07-31 1987-02-07 Sumitomo Pharmaceut Co Ltd オキサゾリジン誘導体
US4892961A (en) * 1985-07-31 1990-01-09 Sumitomo Pharmaceuticals Company, Limited Amino acid derivatives, and their production
EP0213610A1 (en) * 1985-08-31 1987-03-11 Lederle (Japan) Ltd. Azetidin-2-one derivatives and process for production thereof
JPS62103063A (ja) * 1985-10-29 1987-05-13 Sagami Chem Res Center アゼチジノン誘導体の製造方法
GB8528380D0 (en) * 1985-11-18 1985-12-24 Ici Plc Process
GB8531638D0 (en) * 1985-12-23 1986-02-05 Ici Plc Chemical compounds

Also Published As

Publication number Publication date
ATE109764T1 (de) 1994-08-15
EP0229384A2 (en) 1987-07-22
US5134231A (en) 1992-07-28
JPS63165349A (ja) 1988-07-08
EP0229384A3 (en) 1989-08-23
JPH0796547B2 (ja) 1995-10-18
DE3650023T2 (de) 1994-11-24
EP0229384B1 (en) 1994-08-10
DE3650023D1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
DE69001187D1 (de) 6-epifumagillole, ihre herstellung und ihre verwendung.
ATE208374T1 (de) Beta-laktam und cepham verbindungen und ihre herstellung
NO983900D0 (no) Mellomprodukt for fremstilling av terapeutisk aktive forbindelser
ES2054826T3 (es) Peptidos con actividad inhibidora de colagenasa.
ES2005746A6 (es) Un procedimiento para la preparacion de un haluro de piridinio.
DE3167258D1 (en) Synisomer cephalosporin compounds and processes for their preparation
KR960009263B1 (en) Process of producing sulfonylurea derivatives
ES2065994T3 (es) Beta-dicetonas substituidas.
ES2064361T3 (es) Nuevos compuestos.
AU4271389A (en) Phenylalkyl or phenylalkoxyethyl substituted piperazine derivatives
ES2061439T3 (es) Compuesto beta-lactama y su produccion.
GB1381210A (en) Azomethines of 4-amino-5-h-1,2,4-triazin-5-ones process for their production and their use as herbicides
ES550040A0 (es) Un metodo para producir derivados de acido 2-(4-amino susti-tuido-3-oxo-2-isoxazolidinil)-5-oxo-2-tetrahidrofuran-carbo-xilico
ES2096628T3 (es) Derivados heterociclicos.
FI821038A0 (fi) Morfoliner
ATE16706T1 (de) Verfahren zur herstellung von cephalosporinverbindungen.
NO872006D0 (no) Fremgangsmaate for fremstilling av cefalosporinderivater.
ATE153338T1 (de) Phosphor enthaltende azetidin-2-on-derivate
DK0455899T3 (da) Prostaglandin I-analog
DE69022660D1 (de) Verfahren zur Herstellung von Carbamatderivaten des Lankacidines.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 229384

Country of ref document: ES